Find clinical trials for Triple Negative Breast Cancer in Salt Lake City, UT

selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...

The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple...

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patie...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer ...

Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of...

of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors with CCNE1 amplification). Main qu...

This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors.

Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer...